Fund shareholders of HLS Therapeutics Inc
ISIN CA40390B1094 · Canada · LEI 549300QKXFY1J71L2D68
- Fund shareholders
- 6
- Of which ETFs
- 1 5 other funds
- Value held
- 44.7K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Dimensional International Small Cap ETF Dimensional ETF Trust | 4,000 | 12K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Dimensional VA International Small Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 2,903 | 8.7K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| SIIT SCREENED WORLD EQUITY EX-US FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 2,600 | 8.7K $ | 0.01 % | as of May 31, 2026 ↗ |
| LVIP Dimensional International Core Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 2,317 | 7.2K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 2,000 | 6K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| International Small Company Trust John Hancock Variable Insurance Trust | 700 | 2.2K $ | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| SIIT SCREENED WORLD EQUITY EX-US FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 0.01 % | as of May 31, 2026 ↗ |
| Dimensional VA International Small Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
| International Small Company Trust John Hancock Variable Insurance Trust | 0.00 % | as of Jun 30, 2026 ↗ |
| LVIP Dimensional International Core Equity Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00 % | as of Jun 30, 2026 ↗ |
| Dimensional International Small Cap ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| World ex U.S. Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 6 | -1 | 14,520 | -23.7 % |
| 2026Q2 | 7 | -1 | 19,024 | -5.0 % |
| 2026Q1 | 8 | +1 | 20,024 | +14.9 % |
| 2025Q4 | 7 | -2 | 17,424 | -52.0 % |
| 2025Q3 | 9 | 0 | 36,324 | 0.0 % |
| 2025Q2 | 9 | -1 | 36,324 | -3.2 % |
| 2025Q1 | 10 | +1 | 37,524 | +11.9 % |
| 2024Q4 | 9 | -2 | 33,524 | -0.3 % |
| 2024Q3 | 11 | 0 | 33,614 | 0.0 % |
| 2024Q2 | 11 | 0 | 33,614 | 0.0 % |
| 2024Q1 | 11 | 0 | 33,614 | 0.0 % |
| 2023Q4 | 11 | 33,614 |
Cite this page
Titelia. "Fund shareholders of HLS Therapeutics Inc". https://titelia.com/en/stocks/hls-therapeutics-inc-CA40390B1094